The answer to your last question is also very challenging. That demands surveillance across the geographies, and surveillance is more easily done in urban centres and tertiary hospitals than it is in rural communities. That's true in Canada, that's true in the United States, and that's true around the world.
The global burden of AMR is highest in many of the low- and middle-income countries. India reports a very high burden. Parts of Africa and Southeast Asia have extremely high burdens, and they are growing. We know that eastern Europe has high burdens relative to western Europe. We know that the Nordic countries do extremely well with respect to antimicrobial resistance due to a number of policies they have, including understanding who enters the hospital carrying a drug-resistant microbe and being very active in containment of those patients and the like.
It varies widely across the world. It varies substantially within jurisdictions, between rural and urban settings and between cities.